 Johnson Johnson NYSE:JNJs rosy 2023 earnings forecast failed to take the sting off of moderated sales growth and inflationary pressures during the fourth quarter of 2022. For the three-month period to end December 2022, the consumer products and pharmaceutical giant beat on adjusted profit expectations at 2.35 a share, compared to average analyst estimates of 2.23. 